Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
35
GBLI Quote, Financials, Valuation and Earnings
Last price:
$31.55
Seasonality move
:
1.55%
Day range:
$30.39 - $30.39
52-week range:
$26.94 - $37.00
Dividend yield:
4.61%
P/E ratio:
15.27x
P/S ratio:
0.96x
P/B ratio:
0.64x
Volume:
--
Avg. volume:
1.3K
1-year change:
-1.97%
Market cap:
$433.8M
Revenue:
$441.2M
EPS (TTM):
$1.99
Earnings Data
Next earnings date for GBLI
Aug 06
2025
Most recent earnings per share
-$0.30
Missed by $0.67
(May 7/2025)
Consensus Estimate
$0.37
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GBLI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $121.3M | -- | -- | $0.79 | -- |
| 08/06/2025 | Q2 | $120.3M | -- | -- | $0.74 | -- |
| 05/07/2025 | Q1 | $113M | $108.7M | -$0.30 | $0.37 | -$0.67 |
| 03/11/2025 | Q4 | $114M | $108.4M | $0.64 | $0.78 | -$0.14 |
| 11/07/2024 | Q3 | $123M | $111.8M | $0.92 | -- | -- |
| 08/07/2024 | Q2 | $114M | $108.7M | $0.73 | -- | -- |
| 05/08/2024 | Q1 | $90M | $112.3M | $0.82 | $0.60 | $0.22 |
| 03/13/2024 | Q4 | $136M | $109.3M | $0.42 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | $0.55 | $0.79 | -$0.24 |
| 08/08/2023 | Q2 | -- | -- | $0.67 | $0.58 | $0.09 |
| 05/10/2023 | Q1 | -- | -- | $0.17 | $0.70 | -$0.53 |
| 03/09/2023 | Q4 | -- | -- | $0.15 | -- | -- |
| 11/08/2022 | Q3 | -- | -- | $1.60 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.84 | -- | -- |
| 05/09/2022 | Q1 | -- | -- | -$1.03 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | $1.71 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.54 | -- | -- |
| 08/04/2021 | Q2 | -- | -- | $0.43 | -- | -- |
| 05/05/2021 | Q1 | -- | -- | $0.37 | -- | -- |
| 03/08/2021 | Q4 | -- | -- | $0.08 | -- | -- |
| 11/09/2020 | Q3 | -- | -- | -$1.06 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | $2.61 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$3.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $2.02 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.47 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -- | -- | -- |
| 03/02/2017 | Q4 | -- | -- | $1.05 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | $0.47 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | $0.69 | -- | -- |
| 03/01/2016 | Q4 | -- | -- | $1.30 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | $0.14 | -- | -- |
Global Indemnity Group LLC Earnings Questions
-
How Much did Global Indemnity Group LLC Generate in Revenue Last Quarter?
Global Indemnity Group LLC reported $108.7M worth of top line sales in its most recent quarter.
-
Did Global Indemnity Group LLC Beat Earnings Last Quarter?
Global Indemnity Group LLC announced earnings per share of -$0.30 which represents a miss of analyst forecast a $0.37 per share.
-
Is Global Indemnity Group LLC Profitable?
Global Indemnity Group LLC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Global Indemnity Group LLC EPS Next Year?
Global Indemnity Group LLC's earnings are forecast to decrease from $3.12 per share to $3.25 per share next year representing a decrease of -34.62%.
-
When is Global Indemnity Group LLC's Earnings Date?
Global Indemnity Group LLC's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
